July - September 2013, Volume 9, Issue 3

Badiu C

Clinical Trials

Acta Endo (Buc) 2013, 9 (3): 439-444
doi: 10.4183/aeb.2013.439

From the beginning of the new millenium, several trends are characteristic of clinical trials and reflect the dynamics of this area: from evidence-based approach to personalized medicine and pharmacogenomics, from translational medicine to new requirements of ethics and transparency of clinical trials, all these tendencies reflecting the current trends. In order to get enough statistical power, more and more patients are required; therefore a number of dedicated networks for specific disorders appeared. In addition, open access editorial policy is part of the information process both at the beginning (documentation) and at the end (dissemination) of any clinical trial.

Keywords: clinical trial, Orphanet, ENS@T, Evidence-based.

Correspondence: Corin Badiu MD, PhD, “C.I. Parhon” National Institute of Endocrinology, Thyroid Related Disorders, Aviatorilor 34-36, Bucharest, 011863, Romania, E-mail: badicrin@yahoo.co.uk